Clinical Trials
3 trialsNCT02750514 2021-03-22
FRACTION-Lung
Bristol-Myers Squibb
Phase 2 Terminated
NCT00895128 2015-07-13
Study of Erlotinib in Combination With Dasatinib
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00429234 2013-04-04
Gemcitabine and Dasatinib in Advanced Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Completed